103 related articles for article (PubMed ID: 10961691)
21. Regulation of the biochemical function of motif VI of HCV NTPase/helicase by the conserved Phe-loop.
Hartjen P; Medom BK; Reinholz M; Borowski P; Baier A
Biochimie; 2009 Feb; 91(2):252-60. PubMed ID: 18951948
[TBL] [Abstract][Full Text] [Related]
22. Predictive factors of virological non-response to interferon-ribavirin combination therapy for patients infected with hepatitis C virus of genotype 1b and high viral load.
Akuta N; Suzuki F; Sezaki H; Suzuki Y; Hosaka T; Someya T; Kobayashi M; Saitoh S; Watahiki S; Sato J; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2006 Jan; 78(1):83-90. PubMed ID: 16299715
[TBL] [Abstract][Full Text] [Related]
23. Mutagenic and inhibitory effects of ribavirin on hepatitis C virus RNA polymerase.
Vo NV; Young KC; Lai MM
Biochemistry; 2003 Sep; 42(35):10462-71. PubMed ID: 12950173
[TBL] [Abstract][Full Text] [Related]
24. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus virology and new treatment targets.
Meier V; Ramadori G
Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in the discovery of small molecule therapies for HCV.
Myles DC
Curr Opin Drug Discov Devel; 2001 Jul; 4(4):411-6. PubMed ID: 11727306
[TBL] [Abstract][Full Text] [Related]
27. 5'-O-fluorosulfonylbenzoyl esters of purine nucleosides as potential inhibitors of NTPase/helicase and polymerase of Flaviviridae viruses.
Bretner M; Schalinski S; Borowski P; Kulikowski T
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1531-3. PubMed ID: 14565459
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the nucleoside triphosphatase, RNA triphosphatase, and unwinding activities of the helicase domain of dengue virus NS3 protein.
Wang CC; Huang ZS; Chiang PL; Chen CT; Wu HN
FEBS Lett; 2009 Feb; 583(4):691-6. PubMed ID: 19166847
[TBL] [Abstract][Full Text] [Related]
29. A novel Raman spectrophotometric method for quantitative measurement of nucleoside triphosphate hydrolysis.
Jenkins RH; Tuma R; Juuti JT; Bamford DH; Thomas GJ
Biospectroscopy; 1999; 5(1):3-8. PubMed ID: 10219876
[TBL] [Abstract][Full Text] [Related]
30. Characterization of imidazo[4,5-d]pyridazine nucleosides as modulators of unwinding reaction mediated by West Nile virus nucleoside triphosphatase/helicase: evidence for activity on the level of substrate and/or enzyme.
Borowski P; Lang M; Haag A; Schmitz H; Choe J; Chen HM; Hosmane RS
Antimicrob Agents Chemother; 2002 May; 46(5):1231-9. PubMed ID: 11959550
[TBL] [Abstract][Full Text] [Related]
31. A mutational shift from domain III to II in the internal ribosome entry site of hepatitis C virus after interferon-ribavirin therapy.
Ogata K; Kashiwagi T; Iwahashi J; Hara K; Honda H; Ide T; Kumashiro R; Kohara M; Sata M; Watanabe H; Hamada N
Arch Virol; 2008; 153(8):1575-9. PubMed ID: 18592133
[TBL] [Abstract][Full Text] [Related]
32. Implications of finding synergic in vitro drug-drug interactions between interferon-alpha and ribavirin for the treatment of hepatitis C virus.
Buckwold VE
J Antimicrob Chemother; 2004 Mar; 53(3):413-4. PubMed ID: 14963071
[TBL] [Abstract][Full Text] [Related]
33. Ribavirin: is it a mutagen for hepatitis C virus?
Perelson AS; Layden TJ
Gastroenterology; 2007 May; 132(5):2050-2. PubMed ID: 17484896
[No Abstract] [Full Text] [Related]
34. Ecto-nucleotide triphosphatase activity in pathogenic and non-pathogenic Entamoeba: protection from the cytotoxic effects of extracellular ATP.
Cerbón J; Olguín T
Microbios; 1997; 92(372-373):157-70. PubMed ID: 9670549
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antiviral evaluation of 4-fluoropyrazole-3-carboxamide nucleoside derivatives.
Leroy F; Chaves D; Dukhan D; Storer R; Sommadossi JP; Loi AG; Cadeddu A; Fanti M; Boscu N; Bassetti F; Liuzzi M; Gosselin G
Nucleic Acids Symp Ser (Oxf); 2008; (52):617-8. PubMed ID: 18776531
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis C virus helicase/NTPase: an efficient expression system and new inhibitors.
Mukovnya AV; Tunitskaya VL; Khandazhinskaya AL; Golubeva NA; Zakirova NF; Ivanov AV; Kukhanova MK; Kochetkov SN
Biochemistry (Mosc); 2008 Jun; 73(6):660-8. PubMed ID: 18620531
[TBL] [Abstract][Full Text] [Related]
37. Basis for substrate specificity of the Toxoplasma gondii nucleoside triphosphate hydrolase.
Nakaar V; Beckers CJ; Polotsky V; Joiner KA
Mol Biochem Parasitol; 1998 Nov; 97(1-2):209-20. PubMed ID: 9879899
[TBL] [Abstract][Full Text] [Related]
38. An analogue of AICAR with dual inhibitory activity against WNV and HCV NTPase/helicase: synthesis and in vitro screening of 4-carbamoyl-5-(4,6-diamino-2,5-dihydro-1,3,5-triazin-2-yl)imidazole-1-beta-D-ribofuranoside.
Ujjinamatada RK; Baier A; Borowski P; Hosmane RS
Bioorg Med Chem Lett; 2007 Apr; 17(8):2285-8. PubMed ID: 17289387
[TBL] [Abstract][Full Text] [Related]
39. Bluetongue virus core protein VP4 has nucleoside triphosphate phosphohydrolase activity.
Ramadevi N; Roy P
J Gen Virol; 1998 Oct; 79 ( Pt 10)():2475-80. PubMed ID: 9780054
[TBL] [Abstract][Full Text] [Related]
40. A novel imidazole nucleoside containing a diaminodihydro-S-triazine as a substituent: inhibitory activity against the West Nile virus NTPase/helicase.
Ujjinamatada RK; Agasimundin YS; Zhang P; Hosmane RS; Schuessler R; Borowski P; Kalicharran K; Fattom A
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1775-88. PubMed ID: 16438047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
